$FUL News

Citigroup Maintains Buy on H.B. Fuller, Raises Price Target to $75

Deutsche Bank Maintains Buy on H.B. Fuller, Raises Price Target to $72

JP Morgan Upgrades H.B. Fuller (FUL)

JP Morgan Upgrades H.B. Fuller to Overweight, Raises Price Target to $67

H.B. Fuller: Overreaction, Or Proof Of Slowdown

H.B. Fuller Company (FUL) Q2 2026 Earnings Call Transcript

H.B. Fuller Company 2026 Q2 - Results - Earnings Call Presentation

H.B. Fuller Q2 2026 Earnings Call Transcript

H.B. Fuller Makes Recommended Cash Offer To Acquire Advanced Medical Solutions At £2.85 Per Share, Implying £715M Enterprise Value, Expects ~$55M In Run-Rate Synergies

H.B. Fuller Co. (NYSE:FUL) Slides on Inline Earnings and Slightly Disappointing Guidance

H.B. Fuller Raises FY2026 Adj EPS Guidance from $4.55-$4.90 to $4.60-$4.90 vs $4.84 Est

H.B. Fuller Q2 Adj. EPS $1.41 Beats $1.40 Estimate, Sales $950.271M Beat $924.792M Estimate

Top Wall Street Forecasters Revamp H.B. Fuller Expectations Ahead Of Q2 Earnings

UBS Maintains Neutral on H.B. Fuller, Raises Price Target to $71

How The Investment Story For H.B. Fuller (FUL) Is Evolving Without New Analyst Input

Is H. B. Fuller (FUL) Stock Undervalued Right Now?

H.B. Fuller Advances Sustainable Packaging, Enhancing Barrier Coating Solutions, with VerdaFresh, New Advanced Oxygen Barrier Technology

JP Morgan Upgrades H.B. Fuller (FUL)

JP Morgan Upgrades H.B. Fuller to Neutral, Announces $58 Price Target

H.B. Fuller Issues Statement Regarding Value Creation Strategy